LY-225910

SynDRA canonical compound SYN0086902 — structure-anchored drug synonym record

Clinical phase	Preclinical
Primary target(s)	CCKBR
Mechanism of action	CCK receptor antagonist

All known targets

CCKBR

Mechanisms of action (all sources)

CCK receptor antagonist

Cross-references

PubChem CID: 4355450
ChEMBL: CHEMBL37312
ChEBI: 92592
LINCS BRD: BRD-K33864865

Synonyms

RefChem:452997
LY225910
LY225910;LY-225910
KUECXUACQOYKNB-UHFFFAOYSA-N
NCGC00024941-01
Tocris-1018
orb1704397
SCHEMBL9002941
SCHEMBL29934873
CHEBI:92592
HMS3267O07
HMS3411P20
HMS3675P20
IFA04077
BDBM50006842
EX-A11207
AKOS022180694
MS-33149
DB-042155
HY-101352
H20655
LY225910, >=98% (HPLC)
T22941
L005998
SR-01000597461
SR-01000597461-1
BRD-K33864865-001-01-7
BRD-K33864865-001-02-5
2-[2-(5-bromo-1H-indol-3-yl)ethyl]-3-(3-propan-2-yloxyphenyl)-4-quinazolinone

Look up LY-225910 in the interactive SynDRA portal →